The cost and burden of cancer in the European Union 1995-2014
详细信息 查看全文
- 作者：Bengt Jö ; nssona ; bengt.jonsson@hhs.se" class="auth_mail" title="E-mail the corresponding author ; Thomas Hofmarcherb ; thomas.hofmarcher@nek.lu.se" class="auth_mail" title="E-mail the corresponding author ; Peter Lindgrenc ; peter.lindgren@ihe.se" class="auth_mail" title="E-mail the corresponding author ; Nils Wilkingd ; nils.wilking@skane.se" class="auth_mail" title="E-mail the corresponding author
- 关键词：National expenditures on cancer ; Direct costs ; Indirect costs ; EU ; Cost of cancer drugs
- 刊名：European Journal of Cancer
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：66
- 期：Complete
- 页码：162-170
- 全文大小：867 K
文摘
- •
Health expenditures on cancer care have not increased in relative terms, despite the growing relative burden of cancer.
- •
The share of health care expenditures devoted to cancer is small compared to the relative burden of cancer.
- •
Costs for cancer drugs have increased significantly, but this cost increase has been balanced by a relative reduction in hospital care.
- •
Indirect costs from mortality have been reduced over time, easing the societal cost of cancer.